BridgeBio Pharma, Inc. (BBIO) › RevenueBridgeBio Pharma, Inc. (BBIO) — RevenueAnnual figures by period end, from SEC filings.2019-12-31: $40.56M2020-12-31: $8.25M2021-12-31: $69.72M2022-12-31: $77.65M2023-12-31: $9.30M2024-12-31: $221.90M2025-12-31: $502.08M$502.08M2019-12-31Revenue (USD)2025-12-31Period endedRevenueChange YoYSource filing2025-12-31$502.08M+126.3%2026-02-24From 2025-01-012024-12-31$221.90M+2285.3%2026-02-24From 2024-01-012023-12-31$9.30M-88.0%2026-02-24From 2023-01-012022-12-31$77.65M+11.4%2025-02-20From 2022-01-012021-12-31$69.72M+745.1%2024-02-22From 2021-01-012020-12-31$8.25M-79.7%2023-02-23From 2020-01-012019-12-31$40.56M—2022-02-25From 2019-01-01Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)